A systematic review of p53 as a biomarker of survival in patients with osteosarcoma
- 517 Downloads
Osteosarcoma is the most common malignant bone tumor, and the prognosis of patients with osteosarcoma is still unsatisfactory with low survival rates. There are many studies assessing the prognostic role of upregulated p53 in patients presenting osteosarcoma, and there is no consistent finding. To summarize the existing evidence about whether the presence of upregulated p53 was a biomarker of survival in patients with osteosarcoma, we performed a systematic review and meta-analysis of relevant publications. We assessed the effect of upregulated p53 on the 3-year overall survival and the 3-year disease-free survival by calculating the pooled odds ratio (OR) with corresponding 95 % confidence interval (95 %CI). Fifteen studies with a total of 609 patients with osteosarcoma were finally included into the systematic review and meta-analysis. Compared with osteosarcoma patients with low or undetectable p53, patients with upregulated p53 were obviously associated with decreased 3-year overall survival (OR = 0.29, 95 %CI 0.19–0.43, P < 0.001). In addition, patients with upregulated p53 were obviously associated with decreased 3-year disease-free survival (OR = 0.06, 95 %CI 0.02–0.23, P < 0.001). The results from the systematic review and meta-analysis highlight that p53 is an effective biomarker of survival in patients with osteosarcoma. In addition, more studies with a large sample size are needed to identify the effect of p53 expression in osteosarcoma patients.
KeywordsOsteosarcoma p53 Survival Systematic review
This research was supported by grants from the Heilongjiang Provincial Education Department (no. 12511205) and Heilongjiang Provincial Health Department (no. 2011–062).
Conflicts of interest
- 6.Ye ZM, Li WX, Fan SW, Yang DS, Tao HM. Expression of p53 protein and proliferating cell nuclear antigen (PCNA) in osteosarcoma and its prognostic significance [article in Chinese]. Zhejiang Med J. 2000;22:65–7.Google Scholar
- 7.Zhang L, Yang ZY, Tang RY, Mei J, Ai ZS. The relationship with the protein expression of p53, pten and the three-year survival ratios in osteosarcoma patients [article in Chinese]. J Pract Radiol. 2003;19:673–6.Google Scholar
- 9.Bao Y, Li HP, Fan R, Jiang C. Expression of p53 protein in osteosarcoma and its significance [article in Chinese]. Acta Acad Med CPAPF. 2006;15:230–1.Google Scholar
- 11.Zhang SQ, Xiao DM, Zhu YH, Guan H, Li W, Tan JF. Protein expression of p53 in osteosarcoma and the correlation with clinical features and prognosis [article in Chinese]. J Mod Oncol. 2011;19:145–6.Google Scholar